Anti-Ig/BCR [M2B3] monoclonal Antibody
Invented at Netherlands Cancer Institute
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 154776 |
| Applications | FACS IP |
| Antigen/Gene or Protein Targets | Ig/BCR |
| Reactivity | Human |
| Relevance | The B-cell receptor (BCR) is composed of immunoglobulin molecules that form a type 1 transmembrane receptor protein usually located on the outer surface of B cells. Through biochemical signalling and by physically acquiring antigens from the immune synapses, the BCR controls the activation of B-cell. |
| Host | Mouse |
| Immunogen | B cell non-Hodgkin's lymphoma |
| Subclass | IgG1 |
| Myeloma Used | Sp2/0-Ag14 |
| Strain | Balb/c |
| Notes | Fusion partners: SP2/0 x spleen cells origin BALB/C. |
| Research Area | Cell Signaling & Signal Transduction, Immunology |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
